Literature DB >> 34231823

Early detection of SARS-CoV-2 P.1 variant in Southern Brazil and reinfection of the same patient by P.2.

Mariana Soares da Silva1, Meriane Demoliner1, Alana Witt Hansen1, Juliana Schons Gularte1, Flávio Silveira1, Fágner Henrique Heldt1, Micheli Filippi1, Vyctoria Malayhka de Abreu Góes Pereira1, Francini Pereira da Silva1, Larissa Mallmann1, Pietra Fink1, Luana Letícia da Silva2, Matheus Nunes Weber1, Paula Rodrigues de Almeida1, Juliane Deise Fleck1, Fernando Rosado Spilki1.   

Abstract

Multiple variants of the Severe Acute Respiratory Syndrome coronavirus 2 virus (SARS-CoV-2) have been constantly reported across the world. The B.1.1.28 lineage has been evolving in Brazil since February 2020 and originated the P.1 variant of concern (VOC), recently named as the Gamma variant by the newly WHO nomenclature proposal, and P.2 as a variant of interest (VOI). Here we describe an early case of P.1 primary infection in Southern Brazil in late November 2020, soon after the emergence of the variant in Manaus, Northern Brazil. The same male patient was reinfected by another B.1.1.28 variant, namely P.2, in March, 2021. The genomic analysis confirmed genetically significant differences between the two viruses recovered in both infections, the P.1 lineage in the first episode and P.2 in the reinfection. Due the very early detection of P.1, we have also investigated the circulation of P.1 in the same region by differential RT-qPCR, showing that this was an isolated case of P.1 at the time of detection, and this variant has disseminated and became prominent from late January to the end of March, 2021. SARS-CoV-2 recent reports of reinfection have raised critical questions on whether and how well a first infection protects against reinfection.

Entities:  

Year:  2021        PMID: 34231823     DOI: 10.1590/S1678-9946202163058

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  10 in total

1.  Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.

Authors:  Priscila Lamb Wink; Rafaela Ramalho; Francielle Liz Monteiro; Fabiana Caroline Zempulski Volpato; Julia Biz Willig; Otávio von Ameln Lovison; Alexandre Prehn Zavascki; Afonso Luís Barth; Andreza Francisco Martins
Journal:  Microbiol Spectr       Date:  2022-02-16

Review 2.  The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape.

Authors:  Pedro F N Souza; Felipe P Mesquita; Jackson L Amaral; Patrícia G C Landim; Karollyny R P Lima; Marília B Costa; Izabelle R Farias; Mônica O Belém; Yago O Pinto; Heline H T Moreira; Ilana C L Magalhaes; Débora S C M Castelo-Branco; Raquel C Montenegro; Claudia R de Andrade
Journal:  Int J Biol Macromol       Date:  2022-03-15       Impact factor: 8.025

Review 3.  SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines.

Authors:  Desh Deepak Singh; Amna Parveen; Dharmendra Kumar Yadav
Journal:  Front Cell Infect Microbiol       Date:  2021-12-14       Impact factor: 5.293

4.  Phylogenetic-based inference reveals distinct transmission dynamics of SARS-CoV-2 lineages Gamma and P.2 in Brazil.

Authors:  Tiago Gräf; Gonzalo Bello; Felipe Gomes Naveca; Marcelo Gomes; Vanessa Leiko Oikawa Cardoso; Alexandre Freitas da Silva; Filipe Zimmer Dezordi; Mirleide Cordeiro Dos Santos; Katia Correa de Oliveira Santos; Érika Lopes Rocha Batista; Alessandro Leonardo Álvares Magalhães; Fernando Vinhal; Fábio Miyajima; Helisson Faoro; Ricardo Khouri; Gabriel Luz Wallau; Edson Delatorre; Marilda Mendonça Siqueira; Paola Cristina Resende
Journal:  iScience       Date:  2022-03-26

Review 5.  Clinical Characteristics, Transmissibility, Pathogenicity, Susceptible Populations, and Re-infectivity of Prominent COVID-19 Variants.

Authors:  Zhen Yang; Shuo Zhang; Yu-Ping Tang; Sai Zhang; Ding-Qiao Xu; Shi-Jun Yue; Qi-Ling Liu
Journal:  Aging Dis       Date:  2022-04-01       Impact factor: 6.745

6.  Using data from a private provider of telemedicine to assess the severity of the early 2021 Covid-19 wave in Brazil.

Authors:  P M Barbosa; F C da Silva Júnior; G M C Lima; S Bertini; R R de Lima; K A Furuta; C H Mapa; L Roschel; E Oliveira
Journal:  Braz J Med Biol Res       Date:  2022-06-22       Impact factor: 2.904

7.  A Class of Shark-Derived Single-Domain Antibodies can Broadly Neutralize SARS-Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape.

Authors:  Bo Feng; Zhilong Chen; Jing Sun; Tingting Xu; Qian Wang; Haisu Yi; Xuefeng Niu; Jiabin Zhu; Mengzhu Fan; Ruitian Hou; Ying Shao; Sihui Huang; Cuiyun Li; Peiyu Hu; Pingqian Zheng; Ping He; Jia Luo; Qihong Yan; Xiaoli Xiong; Jinsong Liu; Jincun Zhao; Ling Chen
Journal:  Small Methods       Date:  2022-05-18

8.  Viral isolation allows characterization of early samples of SARS-CoV-2 lineage B1.1.33 with unique mutations (S: H655Y and T63N) circulating in Southern Brazil in 2020.

Authors:  Juliana Schons Gularte; Mariana Soares da Silva; Micheli Filippi; Meriane Demoliner; Karoline Schallenberger; Alana Witt Hansen; Vyctoria Malayhka de Abreu Góes Pereira; Fágner Henrique Heldt; Viviane Girardi; Matheus Nunes Weber; Paula Rodrigues de Almeida; Bruno Lopes Abbadi; Maiele Dornelles; Cristiano Valim Bizarro; Pablo Machado; Luiz Augusto Basso; Odir Antonio Dellagostin; Juliane Deise Fleck; Fernando Rosado Spilki
Journal:  Braz J Microbiol       Date:  2022-07-01       Impact factor: 2.214

9.  SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.

Authors:  Georgi K Marinov; Mladen Mladenov; Antoni Rangachev; Ivailo Alexiev
Journal:  PLoS One       Date:  2022-09-09       Impact factor: 3.752

10.  Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.

Authors:  Juliana Schons Gularte; Mariana Soares da Silva; Ana Cristina Sbaraini Mosena; Meriane Demoliner; Alana Witt Hansen; Micheli Filippi; Vyctoria Malayhka de Abreu Góes Pereira; Fágner Henrique Heldt; Matheus Nunes Weber; Paula Rodrigues de Almeida; Andressa Taiz Hoffmann; Andreia Rosane de Moura Valim; Lia Gonçalves Possuelo; Juliane Deise Fleck; Fernando Rosado Spilki
Journal:  Virus Res       Date:  2022-01-29       Impact factor: 3.303

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.